{
  "docId": "019dd923-5efe-75c0-8dff-2e87a7b85930",
  "docSlug": "d74f6dfc5c764997",
  "documentTitle": "2026 Capital Markets Day AM",
  "authorId": "Syncona",
  "authorName": "Syncona",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 41,
  "pageCount": 55,
  "prevPage": 40,
  "nextPage": 42,
  "slideType": "industry_trends",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 56,
  "notes": "Includes a callout box emphasizing portfolio rebalancing during the market downturn.",
  "elementsJson": [
    "headline_text",
    "bar_chart_stacked",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5efe-75c0-8dff-2e87a7b85930/41",
  "deckHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930",
  "deckJsonHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930.json",
  "deckAnchorHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930#slide-41",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.64,
        "y": 0.3
      },
      "kind": "callout",
      "text": "DURING THE MARKET DOWNTURN, WE REBALANCED THE PORTFOLIO – TAKING DIFFICULT DECISIONS AND ENSURING FINANCING TO DATA TO REDUCE FINANCING RISK",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5085700-6893-446f-9eec-e71fd286c815",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.95,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "chart",
      "text": "EQUITY RAISED AND PRIVATE DEBT RAISED IN THE BIOPHARMA SECTOR, 2013 – 2026 (ESTIMATED, $ BILLIONS, WORLDWIDE)",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d82b8ef-dfb4-49f7-90f7-efba2ffac731",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Capital raised ($ billions)",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-832d-736c-a658-bc41b004d7c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.03,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: S&P CapitalIQ and Stifel Investment Banking Analysis; Stifel Biopharma Outlook February 2026.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "593b2c75-b34f-4492-bccd-09504d1fad36",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.9,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Significant capital is available and returning to strong levels in both private and public capital markets",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83e1fd1a-e2d5-4dcb-89ca-883145940967",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "Improved market conditions support delivery of strategy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "569afebb-bec3-4f45-b3d0-ecfe45a25e7f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 45,
      "from": 39,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "913f54b4-72d9-47d7-b021-b19ce8ff34a5",
      "evidence": "The presentation highlights the global burden of disease and the need for innovative solutions",
      "position": 1,
      "objective": "What are the consequences of not addressing the unmet medical needs?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}